<DOC>
	<DOCNO>NCT01689558</DOCNO>
	<brief_summary>1 ) Observe compare curative effect endostatin/recombined Endostatin alliance neoadjuvant chemotherapy Concurrent chemo-radio therapy treat local advance nasopharyngeal darcinoma ; 2 ) Evaluate security tolerability endostatin/recombined Endostatin alliance neoadjuvant chemotherapy Concurrent chemo-radio therapy treat local advance nasopharyngeal darcinoma .</brief_summary>
	<brief_title>Recombine Endostatin With Neoadjuvant Chemotherapy Followed Concurrent Chemoradiation Advanced Nasopharynx Cancer</brief_title>
	<detailed_description>1. experimental group : docetaxel 75mg/m2 iv day 1 +Cisplatin 80mg/m2 iv day 1 +human endostatin 7.5mg/m2 iv day 8-21 three week repeat total two cycle ; follow concurrent chemoradiation ( Cisplatin 80mg/m2 iv day 1,21 +human endostatin 7.5mg/m2 iv day 1-14 Concurrent Intensity-modulated radiation therapy ) 2 . Control group : group : docetaxel 75mg/m2 iv day 1 +Cisplatin 80mg/m2 iv day 1 three week repeat total two cycle ; follow concurrent chemoradiation ( Cisplatin 80mg/m2 iv day 1,21 Concurrent Intensity-modulated radiation therapy )</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Endostatins</mesh_term>
	<criteria>1 . Voluntary sign inform consent form ; 2 ) Age 1870 year old , male female ; 3 ) histologically prove keratinize carcinoma nonkeratinizing carcinoma ; 4 ) nasopharyngeal darcinoma 2010 UICC stag IIIIV A , IV B ; 5 ) measurable Primary tumor ; 6 ) karnofsky score≥70 ; ECOG≥2 ; 7 ) Expected survival≥6 month ; 8 ) Women productive age guarantee use contraceptive study period ; 9 ) Hemoglobin ( HGB ) ≥100g/L , white blood cell ( WBC ) ≥4×109 /L，Platelet（PLT）≥100×109 /L.（or white blood cell platelet less hospital 's Normal low index） ; 10 ) liver function : Alanine amino transferase ( ALAT ) , aspartate aminotransferase ( ASAT ) &lt; 1.5 time upper limit normal index ; total bilirubin &lt; 1.5×ULN ; 11 ) liver function : serum creatinine &lt; 1.5×ULN ; 12 ) severe complication , Hypertensio , Diabetes History mental illness ; 13 ) treatment First treatment process ( H &amp; N Radiation history ; history Concurrent chemoradiotherapy ; chemotherapy history 3 month . 1 . Have distant metastasis ; 2 ) The primary focal tumor lymph node already surgical treatment ( except biopsy ) ; 3 ) Already radiotherapy primary focal lymph node ; 4 ) Patient receive epidermal growth factor target therapy ; 5 ) The primary focal receive chemoradiotherapy immunotherapy ; 6 ) Patient suffer malignant tumor ( except cure basal cell carcinoma carcinoma situ cervix ) ; 7 ) Subject take drug test 1 month ; 8 ) Peripheral Neuropathy &gt; level ; 9 ) pregnant woman Lactating Women Women productive age refuse take contraception observation period ; 10 ) subject severe allergic history idiosyncratic ; 11 ) subject severe pulmonary cardiopathic disease history ; 12 ) refuse incapable sign inform consent form participate trial ; 13 ) drug abuse alcohol addict ; 14 ) subject Personality psychiatric disease , people legal capacity people limited capacity civil conduct .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>nasopharynx cancer , Image department nose pharynx ministry</keyword>
</DOC>